Search hospitals > Kentucky > Lexington

Baptist Health Lexington

Claim this profile
Lexington, Kentucky 40503
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Heart Failure
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Ovarian Cancer
323 reported clinical trials
16 medical researchers
Photo of Baptist Health Lexington in LexingtonPhoto of Baptist Health Lexington in LexingtonPhoto of Baptist Health Lexington in Lexington

Summary

Baptist Health Lexington is a medical facility located in Lexington, Kentucky. This center is recognized for care of Lung Cancer, Breast Cancer, Heart Failure, Non-Small Cell Lung Cancer, Ovarian Cancer and other specialties. Baptist Health Lexington is involved with conducting 323 clinical trials across 337 conditions. There are 16 research doctors associated with this hospital, such as Firas Badin, MD, Gery Tomassoni, Michael Jones, and Hope Cottrill.

Area of expertise

1Lung Cancer
Global Leader
Baptist Health Lexington has run 60 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Baptist Health Lexington has run 48 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
PR positive

Top PIs

Clinical Trials running at Baptist Health Lexington

Lung Cancer
Ovarian Cancer
Breast Cancer
Atrial Fibrillation
Non-Small Cell Lung Cancer
Stroke
Heart Failure
Breast cancer
Uterine Cancer
Cancer
Image of trial facility.

Telisotuzumab Vedotin vs. Docetaxel

for Non-Small Cell Lung Cancer

This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Acasunlimab + Pembrolizumab

for Lung Cancer

This is a multicenter, randomized, open-label, international, Phase 3 trial to evaluate the efficacy and safety of acasunlimab in combination with pembrolizumab versus docetaxel (standard of care) in participants with programmed death ligand 1 (PD-L1)-positive metastatic non-small cell lung cancer (NSCLC) who have been treated with programmed cell death protein 1 (PD-1)/PD-L1 inhibitor and platinum-containing chemotherapy, administered either in combination or sequentially in the metastatic setting.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Baptist Health Lexington?
Where is Baptist Health Lexington located?
Who should I call to ask about financial aid or insurance network?
What insurance does Baptist Health Lexington accept?
What awards or recognition has Baptist Health Lexington received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security